Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M.
The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY.
[Poster]
Web of Science
FullText